US EditionNoul Showcases AI-Powered Cervical Cancer Cell Screening Technology at NVIDIA GTC 2025
- Noul Co., Ltd. Presented innovative cervical cancer screening technology at NVIDIA GTC 2025, showcasing its miLab CER platform powered by NVIDIA Jetson.
- Noul Co., Ltd. Presented its AI-powered cervical cancer screening technology, miLab CER, at NVIDIA GTC 2025, which aims to improve diagnostic accessibility globally.
- MiLab CER can deliver test results in just 15 minutes and has been recognized by WHO-UNITAID as a top global diagnostic solution.
- Noul's partnership with NVIDIA emphasizes leveraging AI to enhance healthcare delivery in underserved regions and developed nations.
Insights by Ground AI
Does this summary seem wrong?
13 Articles
13 Articles
All
Left
1
Center
9
Right
1
Missoulian+12 Reposted by 12 other sources
Noul Showcases AI-Powered Cervical Cancer Cell Screening Technology at NVIDIA GTC 2025
Company Joins NVIDIA Healthcare & Life Sciences (HCLS) Ecosystem to Advance Global Diagnostic Accessibility and Seeks Partnerships with Global Healthcare Opportunities
·Missoula, United States
Read Full ArticleCoverage Details
Total News Sources13
Leaning Left1Leaning Right1Center9Last UpdatedBias Distribution82% Center
Bias Distribution
- 82% of the sources are Center
82% Center
C 82%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
